Factors affecting maternal and perinatal outcomes in HELLP syndrome: Evaluation of 126 cases

Clinical and Experimental Obstetrics and Gynecology

Volumn 37, Issue 3, 2010, Pages 213-216

  Erdemoglu M ^a   Kuyumcuoglu U ^a   Kale, A ^a   Akdeniz, N ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Eclampsia; HELLP; High risk pregnancy; Preeclampsia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BETAMETHASONE; LACTATE DEHYDROGENASE; MAGNESIUM SULFATE;

ABDOMINAL BLEEDING; ACUTE KIDNEY FAILURE; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CLINICAL FEATURE; CONVULSION; ECLAMPSIA; FEMALE; FETUS LUNG MATURITY; FETUS OUTCOME; HELLP SYNDROME; HEMATOMA; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; MULTIPARA; NULLIPARA; PREECLAMPSIA; PREGNANCY OUTCOME; PROTEIN URINE LEVEL; SOLUTIO PLACENTAE; STILLBIRTH; THROMBOCYTE COUNT;

ABRUPTIO PLACENTAE; ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; ANTICONVULSANTS; APGAR SCORE; BETAMETHASONE; BIRTH WEIGHT; BLOOD TRANSFUSION; CESAREAN SECTION; CROSS-SECTIONAL STUDIES; ECLAMPSIA; FEMALE; GLUCOCORTICOIDS; HELLP SYNDROME; HEMATOMA; HUMANS; INFANT, NEWBORN; LUNG; MAGNESIUM SULFATE; MIDDLE AGED; PREGNANCY; RETROSPECTIVE STUDIES; STILLBIRTH;

EID: 77958068132     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am. J. Obstet. Gynecol., 2000, 183, S1.
2. Isler C.M., Rinehart B.K., Terrone D.A., Martin R.W., Magann E.F., Martin J.N. Jr.: "Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome". Am. J. Obstet. Gynecol., 1999, 181, 924.
3. Weinstein L.: "Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy". Am. J. Obstet. Gynecol., 1982, 142, 159.
4. Haddad B., Baton J.R., Livingston J.C., Chahine R., Sibai B.: "Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome". Am. J. Obstet. Gynecol., 2000, 183, 444. (Pubitemid 30651095)
5. Osmanagaoglu M.A., Osmanagaoglu S., Ulusoy H., Bozkaya H.: "Maternal outcome in HELLP syndrome requiring intensive care management in a Turkish hospital". Sao Paulo Med. J., 2006, 124, 85. (Pubitemid 44207817)
6. Mattar F., Sibai B.: "Eclampsia. VIII. Risk factors for maternal morbidity". Am. J. Obstet. Gynecol., 2000, 182, 307. (Pubitemid 30127340)
7. Audibert F., Friedman S.A., Frangieh A.Y., Sibai B.M.: "Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome". Am. J. Obstet. Gynecol., 1996, 175, 460. (Pubitemid 26391008)
8. Ellison J., Sattar N., Greer I.: "HELLP syndrome: mechanisms and management". Hosp. Med., 1999, 60, 243.
9. Rahman T.M., Wendon J.: "Severe hepatic dysfunction in pregnancy". QJM, 2002, 95, 343.
10. Sibai B.M.: "The HELLP syndrome (hemolysis, elevated liver enzyme levels, and low platelets): much ado about nothing?". Am. J. Obstet. Gynecol., 1990, 162, 311.
11. Martin J.N Jr., Rinehart B.K., May W.L., Magann E.F., Terrone D.A., Blake P.G.: "The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification". Am. J. Obstet. Gynecol., 1999, 180, 1373.
12. Schmorl G.: "Pathologisch anatomische Untersuchungen über puerperal eklampsia". Leipzig, FCW Vogel, 1893.
13. Magann E.F., Martin J.N.: "Twelve steps to optimal managementof HELLP syndrome". Clin. Obstet. Gynecol., 1999, 42, 532.
14. Cavkaytar S., Ugurlu E.N., Karaer A., Tapisiz O.L., Danisman N.: "Are clinical symptoms more predictive than laboratory parameters or adverse maternal outcome in HELLP syndrome?". Acta Obstet. Gynecol. Scand., 2007, 86, 648. (Pubitemid 46801803)
15. Haddad B., Barton J.R., Livingston J.C., Chahine R., Sibai B.M.: "Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome". Am. J. Obstet. Gynecol., 2000, 183, 444.
16. McKenna J., Dover N.L., Brame R.G.: "Pre-eclampsia associated with the syndrome of hemolysis, elevated liver enzymes and low platelets in severe pre-eclampsia-eclampsia". Obstet. Gynecol., 1983, 62, 751.
17. Gilbert W.M., Towner D.R., Field N.T., Anthony J.: "The safety and utility of pulmonary artery catheterization in severe preeclampsia and eclampsia". Am. J. Obstet. Gynecol., 2000, 182, 1397.
18. Magann E.F., Martin J.N.: "Twelve steps to optimal management of HELLP syndrome". Clin. Obstet. Gynecol., 1999, 42, 532.
19. Kim H.Y., Sohn Y.S., Lim J.H., Kim E.H., Kwon J.Y., Park Y.W., Kim Y.H.: "Neonatal outcome after preterm delivery in HELLP syndrome". Yonsei Med. J., 2006, 30, 393.
20. Aslan H., Gul A., Cebeci A.: "Neonatal outcome in pregnancies after preterm delivery for HELLP syndrome". Gynecol. Obstet. Invest., 2004, 58, 96.
21. Abramovici D., Friedman S.A., Mercer B.M., Audibert F., Kao L., Sibai B.M.: "Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?". Am. J. Obstet. Gynecol., 1999, 180, 221.